Kennedy Opposition Halts Device User Fee, Third-Party Expansion Momentum
This article was originally published in The Gray Sheet
Executive Summary
House and Senate conferees are likely to include Prescription Drug User Fee Act (PDUFA) reauthorization and medical device reforms in the Public Health Security and Bioterrorism Response Act of 2001 (HR 3448) when they meet to reconcile the measure, as early as the week of April 15
You may also be interested in...
Tauzin Will Tackle Device Reforms Outside PDUFA; Eshoo Urges Hearings
House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization
Device User Fee Proposal To Be Discussed By HIMA Board At Annual Meeting
A discussion on device user fees between a top health official in the Office of Management and Budget and the Health Industry Manufacturers Association board of directors suggests stepped-up efforts by the White House to generate support for its budget proposal and a potential willingness on the part of large device firms to reconsider their past opposition to user fees.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.